Use of lobeline for the treatment of nicotine withdrawal

Details Use of lobeline for the treatment of nicotine withdrawal Use of lobeline for the treatment of nicotine withdrawal

A - Human Necessities

61

K

A61K 31/445 (2006.01) A61K 9/22 (2006.01) A61K 31/439 (2006.01) A61K 31/44 (2006.01) A61K 31/4425 (2006.01) A61K 31/4545 (2006.01) A61K 31/455 (2006.01) A61K 31/465 (2006.01) G01N 33/52 (2006.01)

Patent

CA 2174747

The present application features methods and articles of manufacture for alleviating acute symptoms of nicotine withdrawal and as an aid in smoking cessation. The invention features lobeline held in sublingual tablets for administration to the sublingual and nasal mucosa.

La présente invention se rapporte à des procédés et à des articles permettant de soulager des symptômes de sevrage de nicotine aigus et d'aider une personne à cesser de fumer. Ce procédé consiste à administrer de la lobéline, dans des comprimés sublinguaux, aux muqueuses nasales et sublinguales.

Affiliated with

Also associated with

Rating

Use of lobeline for the treatment of nicotine withdrawal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of lobeline for the treatment of nicotine withdrawal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lobeline for the treatment of nicotine withdrawal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1529777